Standards & Regulation

Cytiva is working to address increasing demand for flexibility and component interchangeability.

From chasing drug lords to advising US presidents, it’s fair to say Robert Pinco has enjoyed a varied career.

Can blood cancer care be improved to ensure that patients from minority groups receive equitable treatment?

The women’s health treatment landscape is devoid of relevant options. What can pharma do to improve the situation?

ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.

Roche’s Kowid Ho talks us through a career spent shaping regulation and striving for pharmaceutical excellence.

To see continued progress, the pharma and tech industries must collaborate.

Determining full versus empty capsids remains a key challenge with adeno-associated viral vectors.

How will bureaucratic red tape affect pharma’ ability to support women seeking abortions?

Why pharma and the high tech sector should band together for the sake of innovation.